Studies on calcium modulatory activities of 2,6,6-trimethyl-3-acetyl-4- aryl-5-oxo-1,4,5,6,7,8-hexahydroquinoline derivatives

Arzneimittel-Forschung/Drug Research

Volumn 49, Issue 10, 1999, Pages 824-829

  Altaş, Yeşim ^a   Şafak, Cihat ^a   Batu, Özlem S ^b   Erol, Kevser ^b  

^a HACETTEPE UNIVERSITY   (Turkey)

^b ESKISEHIR OSMANGAZI UNIVERSITY   (Turkey)

Author keywords

Calcium antagonists; Calcium modulatory activity; Hexahydroquinoline derivatives; Synthesis

Indexed keywords

2,6,6 TRIMETHYL 3 ACETYL 4 (2 BROMOPHENYL) 5 OXO 1,4,5,6,7,8 HEXAHYDROQUINOLINE; 2,6,6 TRIMETHYL 3 ACETYL 4 (3 FLUOROPHENYL) 5 OXO 1,4,5,6,7,8 HEXAHYDROQUINOLINE; 2,6,6 TRIMETHYL 3 ACETYL 4 (3 NITROPHENYL) 5 OXO 1,4,5,6,7,8 HEXAHYDROQUINOLINE; CALCIUM CHANNEL; CALCIUM ION; NICARDIPINE; NITRENDIPINE; QUINOLINE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CALCIUM TRANSPORT; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG POTENCY; DRUG STRUCTURE; ILEUM; ISOLATED ARTERY; LAMB; NONHUMAN; RABBIT; SMOOTH MUSCLE RELAXATION; STRUCTURE ANALYSIS;

EID: 0032722734     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0031-1300509     Document Type: Article

References (28)

1. [1] Wehinger, E., Gross, R., Ann. Rep. Med. Chem. 21, 85 (1986)
2. [2] Janis, R. A., Triggle, D. J., J. Med. Chem. 26, 775 (1983)
3. [3] Hess, P., Lansman, J. P., Tsien, R. W., Ann. Rev. Physiol. 311, 538 (1984)
4. [4] Kendall, H. E., Luscombe, D. K., Calcium Channel Blocking Drugs, Progress in Medicinal Chemistry, Elsevier Science Publishers, Amsterdam (1987)
5. [5] Winifred, G., Nayler, D. S., Calcium Antagonists, Academic Press, London (1988)
6. [6] Triggle, D. J., Handbook of Experimental Pharmacology: Calcium Channel Agonists and Antagonists, G. V. R. Born (ed.), p. 115, Springer Verlag, Heidelberg (1988)
7. [7] Rose, U., Arch. Pharm. 323, 281 (1990)
8. [8] Rose, U., Arzneim.-Forsch./Drug Res. 39 (II), 1393 (1989)
9. [9] Rose, U., J. Hetero. Chem. 27, 237 (1990)
10. [10] Rose, U., Arzneim.-Forsch./Drug Res. 41 (I), 199 (1991)
11. [11] Rose, U., Pharm. Acta Helv. 66, 68 (1991)
12. [12] Şafak, C., Şahin, I., Sunal, R., Arzneim.-Forsch./ Drug Res. 40 (I), 119 (1990)
13. [13] Şafak, C., Şahin, I., Sunal, R., Arzneim.-Forsch./ Drug Res. 43 (II), 1052 (1993)
14. [14] Şafak, C., Ozkanh, F., Erol, K., Arzneim.-Forsch./ Drug Res. 45 (II), 1154 (1995)
15. [15] Iwanami, M., Shibanum, T., Fujimato, M. et al., Chem. Pharm. Bull. 27, 1426 (1979)
16. [16] Rose, U., Chem. Zentr. 115, 55 (1991)
17. [17] Rose, U., Drager, M., J. Med. Chem. 35, 2238 (1992)
18. [18] Lacey, M. J., J. Chem. 23, 841 (1970)
19. [19] Fleckenstein, A., Fleckenstein-Grun, G., Byon, Y. K., Arzneim.-Forsch./Drug Res. 27 (I), 562 (1977)
20. [20] Godfraind, T., Kaba, A., J. Pharmacol. 36, 549 (1969)
21. [21] Spedding, M., Acta Pharmacol. 318, 234 (1982)
22. [22] Bowman, W. C., Raud, M. J., Textbook of Pharmacology, Blackwell Scientific Publ., New York (1980)
23. [23] Hantzsch, A., Justus Liebigs Ann. Chem. 215, 1 (1882)
24. [24] Eisner, U., Kuthan, U., J. Chem. Rev. 72, 1 (1972)
25. [25] Philips, A. P., J. Am. Chem. Soc. 71, 4003 (1949)
26. [26] Homer, R. F., J. Chem. Soc. 1574 (1958)
27. [27] Ertan, M., Balkan, A., Saraç, S., Arch. Pharm. (Weinheim) 324, 135 (1991)
28. [28] Kazda, S., Garthoff, B., Meyer, H., Arzneim.-Forsch./Drug Res. 30 (II), 2144 (1980)